Eva Garland Consulting’s unique expertise in science and finance has supported innovators in leveraging over $2 billion in funding for transformative technologies.
Trending
Upcoming Webinar — Winning NIH SBIR Grants in 2026: Key Solicitation Updates + Expert Q&A
Stay ahead of the latest NIH SBIR/STTR changes. Join EGC experts Brandon Turner, Ph.D., and Ranjay Jayadev, Ph.D., for this live webinar covering key updates to the 2026 NIH SBIR/STTR solicitation, including proposal submission limits, new review policies, and upcoming deadlines, followed by a live Q&A to help you strengthen your next application.
EGC's August Newsletter
This month, EGC spotlights TARGAN's journey from early NSF SBIR funding to its acquisition by Merck Animal Health, demonstrating how non-dilutive funding can accelerate breakthrough technologies from concept to commercialization. We also highlight our upcoming webinar covering the latest NIH SBIR/STTR solicitation updates, and feature new funding opportunities from DOE, DoW, NIH, ARPA-H, and NSF, including several large-scale programs supporting high-impact scientific innovation.
Read Now — Top 10 Compliance Pitfalls Every New SBIR Awardee Should Know
Stay compliant from day one. Learn the 10 most common compliance mistakes new SBIR/STTR awardees make, from timekeeping and project cost accounting to documentation and audit readiness, and the practical steps you can take to protect your funding and avoid costly setbacks.
Client Highlights
Pascall Systems
Pascall Systems Secures More Than $13.6 Million from NIH to Personalize Anesthesia and Improve Surgical Outcomes
Medgene
Veterinary Diagnostics and Vaccines Company Receives USDA, NIH, and DHA Funding...
TARGAN
From NSF SBIR Award to Merck Acquisition: TARGAN's Journey to Improving Animal Health
PediaMetrix
NIH and NSF Funding Powers PediaMetrix's AI-Driven Pediatric Screening Platform...
Crystal Sonic
Solid Financial Foundation Propels Semiconductor Manufacturing Technology...
Minerva Lithium
Minerva Lithium’s Funding Strategy Advances Its Vision for a More Sustainable Energy Supply
DataJoint
A Strategic Funding Roadmap Propels DataJoint’s Leadership in Scientific Workflows...
Our Clients Have Secured
$1,991,689,721
In Non-dilutive Funding
“Our team from EGC has been extremely prompt, professional, and knowledgeable. We were considering hiring a part time administrator to help with grants management and book-keeping, but EGC has been able to provide that service with more expertise, and they do so more efficiently. I highly recommend them!”
Brian Lawson, Co-Founder
“Our company exists today because of EGC. As cost intensive as biotech is, and reticent it is to fund new science (unchartered), we’ve had to rely on any and every resource available to keep WinSanTor alive. We are now about to enter phase 3 as the first and only company regrowing and repairing peripheral nerve damage (aka peripheral neuropathy), and Eva and her team were there every step of the way. They helped us turn over every rock, and with their help, we’ve received tens of millions of dollars of funding that literally kept the company afloat. They have an amazing team, which we now consider part of our own company as far as desire and commitment.”
Stanley Kim, Co-Founder & CEO
“Working with EGC team has been critical in identifying and applying for non-dilutive grant opportunities. The team has done all the heavy lifting while helping to navigate the application process, optimizing the project rationales and providing all the help we need to navigate towards success. I would highly recommend the EGC work if you are looking to submit successful applications across all relevant funding bodies.”
Mitch Raponi, Co-Founder & CEO
“I have used EGC for 4 years now and I continue to be impressed with their team and the product offerings that come with their engagements. We began using some of their grant budget consulting this year and I am so impressed!”
Alli Truttmann, CEO
“Lu Lu has been a pleasure to work with. She is insightful and understood our technology and business plans well. I think she’s drafted an excellent strategic plan for us to pursue non-dilutive funding opportunities.”
Michael Emanuel, Founder & CEO
“I have the utmost respect for the professionalism and hard work displayed by my team at EGC. They are fantastic!”


























































